Press kit · 2026
Everything an editor needs
Logo files, the tagline, our mission and boilerplate, spokespeople and story angles — plus a one-page PDF you can take into a story meeting. Use it freely; check the usage notes before setting the wordmark.
Tagline
Peptide therapy for cellular renewal.
Short form, for captions and lower thirds: physician-led peptide therapy. US sourced, US manufactured, batch tested.
Mission
Why Mino exists
Mino exists to move peptide therapy out of the gray market and into medicine. Every protocol is written by a licensed physician, every vial and pen is made in the United States and batch tested for identity, purity and potency, and every fill is dispensed through a licensed pharmacy partner.
Members join Mino Passport, which pairs physician visits with pricing stated plainly, so the care behind a peptide is as accountable as the molecule itself.
Logo
The wordmark
- Set the wordmark as (mino), lowercase, parentheses closed tight.
- Deep sage or ink on bone, and bone reversed out of deep sage. No other colorways.
- Do not stretch, rotate, outline, or add shadows and effects.
- Leave clear space on all sides equal to the height of the wordmark.
- Award seals refer to Mino NAD+ specifically, not the full catalog.
At a glance
The company in four lines
Model
Physician-led peptide program: consult, protocol, prescription, pharmacy fill.
Membership
Mino Passport at $149, $299 or $399 a month, including physician visits and member pricing on every fill.
Catalog
NAD+, GLP2-T, blends and single peptides, in pens and vials.
Sourcing
US sourced, US manufactured, third-party batch tested.
- Audience reached, 2026
- 88M
- Press placements
- 64
- Awards
- 2
Boilerplate
Copy this as written
Mino is a physician-led peptide program. Members consult a licensed physician, receive a protocol written for them, and have their prescription filled by a US pharmacy partner. Every peptide Mino dispenses is US sourced, US manufactured and batch tested. Mino NAD+ was named Best Peptide in Los Angeles Magazine's Best of L.A. Beauty 2026.
Talk to us
Dr. Amy B. Lewis and Mino's clinical leads take interviews on peptide safety, sourcing, GLP therapy and pharmacy infrastructure. We answer press mail the same day.